EUVIMEDEUVIMED entdecken
Crossref

Effects of BRCA variation on prognosis in patients with nonmetastatic breast cancer

Alper Türkel iD, Ilknur Deliktaş Onur, Hicran Anik, Irem Öner, Haktan Bağiş Erdem, Taha Bahsi, Özge Özalp, Berna Öksüzoğlu, Öztürk Ateş, Cengiz Karaçin

Annals of Human Genetics · 2024

DOI: 10.1111/ahg.12577 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Human Genetics, 2024. Verfasst von Alper Türkel und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Dr. Abdurrahman Yurtaslan Ankara Oncology Research and Training Hospital, Ankara, Turkey. Hauptthemen laut MEDLINE: BRCA1 Protein, BRCA2 Protein, Breast Neoplasms. Die Arbeit nennt 28 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

To compare the clinicopathological characteristics of nonmetastatic breast cancer patients with and without BRCA variations and to investigate the impact of BRCA variations on prognosis.

Methods

This retrospective single‐center study involved an analysis of 938 patients with localized or locally advanced breast cancer who underwent BRCA variation testing. The patients were divided into three groups: 757 were without BRCA variation, 64 were with BRCA1 variation, and 117 were with BRCA2 variation.

Results

In patients with BRCA1 variation, the Ki67, grade, and frequency of triple‐negative breast cancer were significantly higher than in patients without BRCA variation and with BRCA2 variation. The 5‐year disease‐free survival in patients with BRCA1 variation was significantly worse than the other two groups (without BRCA, BRCA1, and BRCA2; 87.7%, 69.9%, and 95.3%, respectively, p = 0.049). Multivariate analysis detected no significant difference between groups. The pathological complete response rates with neoadjuvant therapy were significantly better in patients with BRCA variations than those without BRCA variations (49.2% vs. 29.6%, p = 0.024).

Conclusion

Patients with BRCA1 variation had more aggressive tumor characteristics, such as higher Ki67 and higher grade. Also, triple‐negative breast cancer was more common. The presence of BRCA1 variation may worsen survival outcomes. Neoadjuvant treatment responses of patients with BRCA variations were significantly better, and neoadjuvant treatment may contribute to survival outcomes in nonmetastatic patients with BRCA variations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BRCA1 ProteinBRCA2 ProteinBreast NeoplasmsHumansFemaleMiddle AgedPrognosisAdultRetrospective StudiesAgedTriple Negative Breast NeoplasmsDisease-Free SurvivalKi-67 AntigenNeoadjuvant Therapy

Stichwörter der Autor:innen

BRCA variationsbreast cancergeneticsurvival

Substanzen

BRCA1 ProteinBRCA2 ProteinBRCA1 protein, humanBRCA2 protein, humanKi-67 Antigen

Autor:innen und Institutionen

  • Department of Medical Oncology, Dr. Abdurrahman Yurtaslan Ankara Oncology Research and Training Hospital, Ankara, Turkey.
  • Department of Medical Genetics, Etlik City Hospital, Ankara, Turkey.
  • Department of Medical Genetics, Dr. Abdurrahman Yurtaslan Ankara Oncology Research and Training Hospital, Ankara, Turkey.
  • Department of Medical Oncology, Etlik City Hospital, Ankara, Turkey.

ORCID-Profile: Alper Türkel

Zitieren

APA

Türkel, A., Onur, I. D., Anik, H., Öner, I., Erdem, H. B., Bahsi, T., Özalp, Ö., Öksüzoğlu, B., Ateş, Ö., & Karaçin, C. (2024). Effects of BRCA variation on prognosis in patients with nonmetastatic breast cancer. Annals of Human Genetics. https://doi.org/10.1111/ahg.12577

Vancouver

Türkel A, Onur ID, Anik H, Öner I, Erdem HB, Bahsi T, et al. Effects of BRCA variation on prognosis in patients with nonmetastatic breast cancer. Annals of Human Genetics. 2024. doi:10.1111/ahg.12577

BibTeX
@article{Trkel2024,
  author = {Türkel, Alper and Onur, Ilknur Deliktaş and Anik, Hicran and Öner, Irem and Erdem, Haktan Bağiş and Bahsi, Taha and Özalp, Özge and Öksüzoğlu, Berna and Ateş, Öztürk and Karaçin, Cengiz},
  title = {Effects of BRCA variation on prognosis in patients with nonmetastatic breast cancer},
  journal = {Annals of Human Genetics},
  year = {2024},
  doi = {10.1111/ahg.12577}
}
Kostenlos starten →